BaseLaunch supports carefully selected ventures over the course of 15 months and runs in two phases. During this time, the BaseLaunch team as well as highly experienced advisors work very closely with the startups. All applications are initially reviewed and admitted into phase I and II by our selection committee, which includes experts from the healthcare industry and seasoned entrepreneurs.
Phase I: September 14, 2018 – November 30, 2018
Phase II: January – December , 2019
Next deadline to apply
In phase I, the participants work closely with the BaseLaunch Team as well as relevant advisors from areas such as business development, preclinical development, regulatory affairs, legal, IP. For advisory services, financial support through BaseLaunch can be as high as 10,000 Swiss francs per project. Tailored working sessions are also offered. At the end of Phase I, the Selection Committee chooses startups entering Phase II of BaseLaunch.
In Phase II, the selected startups receive grants of up to 250,000 Swiss francs per company to further de-risk the projects and reach key value inflection milestones as well as access to state of the art infrastructure at the Switzerland Innovation Park Basel Area. In order to be eligible, startups need to be incorporated and/or legally registered in the Basel region.
BaseLaunch offers non-dilutive financial support in the form of grants and sponsored services (e.g. for consulting services). Our Healthcare Partners offer direct, no strings attached access to valuable industry knowledge and market know-how. Our network of advisors from areas such as business development, science, preclinical development and legal as well as seasoned healthcare entrepreneurs offers support to the startups. Finally, equipped, ready-to-use labs free of charge for participants are available.
During Phase I, financial support through BaseLaunch for advisory services can be as high as 10,000 Swiss Francs per project.
For companies in Phase II, grants of up to 250,000 Swiss francs are available. Funding should be used to reach key value inflection milestones to further de-risk the projects. The amount of funding may vary according to project requirements. Furthermore, BaseLaunch will actively work with the startups to raise additional non-dilutive funding from foundations and government grants as well as facilitating contacts to business angels, venture funds, and family offices.
Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche and Roivant are our Healthcare Partners and are engaging with us to find and support transformational innovations that solve unmet medical needs. Through their participation in the Selection Committee, our Healthcare Partners offer direct, no strings attached access to valuable industry knowledge and experience relevant to develop and boost transformative healthcare solutions.
Besides support from the BaseLaunch Team and the Selection Committee, BaseLaunch also offers participants expert advice tailored to their particular needs. Our advisors are seasoned biopharma professionals and entrepreneurs with broad and deep experience in key areas relevant to building healthcare ventures (e.g. finance, legal, intellectual property, research and development, regulatory affairs, and more). Additionally, BaseLaunch is well positioned to help bringing in key people with relevant experience to further professionalize the business idea.
BaseLaunch also offers equipped, ready-to-use laboratory and office space, both free of charge, at the Switzerland Innovation Park Basel Area in Allschwil. For translational experiments and special types of equipment, core facilities of our partners may be accessible. Once the program ends, startups may continue to operate from the Switzerland Innovation Park by assuming the costs of the lab and office space.
Hear what our startups, team and selection committee members experienced in our first year – and find out more about what makes BaseLaunch unique.